TQB2618 is a human IgG4 monoclonal antibody (mAb) targeting TIM-3/HAVCR2/CD366. When used in combination with anti-PD-1 drugs, TQB2618 can activate immune cell functions and induce significant anti-tumor activity.
Target:
Immunology/Inflammation related
* VAT and and shipping costs not included. Errors and price changes excepted
